Control of visceral leishmaniasis in latin america-a systematic review.

Código QR

Control of visceral leishmaniasis in latin america-a systematic review.

<h4>Background</h4>While three countries in South Asia decided to eliminate anthroponotic visceral leishmaniasis (VL) by 2015, its control in other regions seems fraught with difficulties. Is there a scope for more effective VL control in the Americas where transmission is zoonotic? We r...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gustavo A S Romero, Marleen Boelaert
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2010
Materias:	Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/b23d1f78e7a642c28c8d765925e8f9a9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms.
por: Tapan Bhattacharyya, et al.
Publicado: (2013)

Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006.
por: Marie-Eve Raguenaud, et al.
Publicado: (2007)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans.
por: Prabin Dahal, et al.
Publicado: (2021)

A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?
por: Johan van Griensven, et al.
Publicado: (2014)

Predictive models for the diagnostic of human visceral leishmaniasis in Brazil.
por: Tália S Machado de Assis, et al.
Publicado: (2012)

Early clinical manifestations associated with death from visceral leishmaniasis.
por: Valdelaine Etelvina Miranda de Araújo, et al.
Publicado: (2012)

Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
por: Kyoko Fujisawa, et al.
Publicado: (2021)

Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysis.
por: Vinícius Silva Belo, et al.
Publicado: (2014)

Enhanced attraction of sand fly vectors of Leishmania infantum to dogs infected with zoonotic visceral leishmaniasis.
por: Ifhem Chelbi, et al.
Publicado: (2021)

Cases and distribution of visceral leishmaniasis in western São Paulo: A neglected disease in this region of Brazil.
por: Regiane Soares Santana, et al.
Publicado: (2021)

Correction: Enhanced attraction of sand fly vectors of Leishmania infantum to dogs infected with zoonotic visceral leishmaniasis.
por: Ifhem Chelbi, et al.
Publicado: (2021)

Visceral leishmaniasis outbreak in South Sudan 2009-2012: epidemiological assessment and impact of a multisectoral response.
por: Abdinasir Abubakar, et al.
Publicado: (2014)

Correction: Enhanced attraction of sand fly vectors of Leishmania infantum to dogs infected with zoonotic visceral leishmaniasis
por: Ifhem Chelbi, et al.
Publicado: (2021)

Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.
por: Shri Prakash Singh, et al.
Publicado: (2011)

Inequalities of visceral leishmaniasis case-fatality in Brazil: A multilevel modeling considering space, time, individual and contextual factors.
por: Gláucia Cota, et al.
Publicado: (2021)

Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
por: Vivian T Martins, et al.
Publicado: (2013)

Nasal, oral and ear swabs for canine visceral leishmaniasis diagnosis: new practical approaches for detection of Leishmania infantum DNA.
por: Sidney de Almeida Ferreira, et al.
Publicado: (2013)

Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis.
por: Doumet Georges Helou, et al.
Publicado: (2021)

The human immune response to saliva of Phlebotomus alexandri, the vector of visceral leishmaniasis in Iraq, and its relationship to sand fly exposure and infection.
por: Ines Lakhal-Naouar, et al.
Publicado: (2021)

Comparative analysis of salivary gland transcriptomes of Phlebotomus orientalis sand flies from endemic and non-endemic foci of visceral leishmaniasis.
por: Michaela Vlkova, et al.
Publicado: (2014)

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.
por: Noushin Saljoughian, et al.
Publicado: (2013)

Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.
por: Dagimawie Tadesse, et al.
Publicado: (2021)

The increased presence of repetitive motifs in the KDDR-plus recombinant protein, a kinesin-derived antigen from Leishmania infantum, improves the diagnostic performance of serological tests for human and canine visceral leishmaniasis.
por: Williane Fernanda Siqueira, et al.
Publicado: (2021)

Diagnosis of human visceral pentastomiasis.
por: Dennis Tappe, et al.
Publicado: (2009)

Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.
por: Matthias Witschel, et al.
Publicado: (2012)

Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.
por: Aschalew Tamiru, et al.
Publicado: (2021)

Human leishmaniasis vaccines: Use cases, target population and potential global demand.
por: Stefano Malvolti, et al.
Publicado: (2021)

Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis.
por: Iva Rohoušová, et al.
Publicado: (2012)

Diagnostic accuracy of the Leishmania OligoC-TesT and NASBA-Oligochromatography for diagnosis of leishmaniasis in Sudan.
por: Alfarazdeg A Saad, et al.
Publicado: (2010)

Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients.
por: Romain Guery, et al.
Publicado: (2021)

Leptospirosis in pregnancy: A systematic review.
por: Sujitha Selvarajah, et al.
Publicado: (2021)

Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme.
por: Rinki Deb, et al.
Publicado: (2021)

Peridomestic natural breeding sites of Nyssomyia whitmani (Antunes and Coutinho) in an endemic area of tegumentary leishmaniasis in northeastern Argentina.
por: Mariana Manteca-Acosta, et al.
Publicado: (2021)

The burden of zoonoses in Paraguay: A systematic review.
por: Liz Paola Noguera Zayas, et al.
Publicado: (2021)

The burden of zoonoses in Paraguay: A systematic review
por: Liz Paola Noguera Zayas, et al.
Publicado: (2021)

Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review.
por: Michael Abouyannis, et al.
Publicado: (2021)

IgG3 and IL10 are effective biomarkers for monitoring therapeutic effectiveness in Post Kala-Azar Dermal Leishmaniasis.
por: Shilpa Sengupta, et al.
Publicado: (2021)

Leishmaniasis: A new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease.
por: Laura Botana, et al.
Publicado: (2021)

First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
por: Cesar Miranda-Verastegui, et al.
Publicado: (2009)

IgG3 and IL10 are effective biomarkers for monitoring therapeutic effectiveness in Post Kala-Azar Dermal Leishmaniasis
por: Shilpa Sengupta, et al.
Publicado: (2021)